Training data from https://doi.org/10.1039/C8SC04228D (8/10) · 10.1039/C8SC04228D
查看HCID58204377
1-(4-(2-(1-isopropyl-3-(methoxymethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropan-2-ol
1-[4-[2-[5-(methoxymethyl)-2-propan-2-yl-1,2,4-triazol-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]pyrazol-1-yl]-2-methylpropan-2-ol
C25H31N7O3477.6 g/mol
IDENTITY
结构与身份
- 标准SMILES
- COCc1nc(-c2cn3c(n2)-c2ccc(-c4cnn(CC(C)(C)O)c4)cc2OCC3)n(C(C)C)n1
- InChIKey
- OFMJUBYHACLFDA-UHFFFAOYSA-N
- 分子式
- C25H31N7O3
- 平均分子量
- 477.6 g/mol
- 单同位素质量
- 477.24883788
COMPUTED
结构计算性质
- XLogP
- 1.3
- 极性表面积
- 105 Ų
- 氢键供体
- 1
- 氢键受体
- 7
- 可旋转键
- 7
- 重原子
- 35
- 形式电荷
- 0
- 复杂度
- 713
ALIASES
名称与别名
SCHEMBL11967473OFMJUBYHACLFDA-UHFFFAOYSA-N1-(4-(2-(1-isopropyl-3-(methoxymethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropan-2-ol
REACTIONS
参与反应
uspto-grants-2012_08 · 10.6084/m9.figshare.5104873.v1 · US08242104B2
查看uspto-grants-2015_12 · 10.6084/m9.figshare.5104873.v1 · US09198918B2
查看uspto-grants-2014_07 · 10.6084/m9.figshare.5104873.v1 · US08785626B2
查看uspto-grants-2013_01 · 10.6084/m9.figshare.5104873.v1 · US08343955B2
查看uspto-grants-2013_11 · 10.6084/m9.figshare.5104873.v1 · US08586574B2
查看